Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 95-97

  De La Serna, J ^a   Bornstein, R ^a   Garcia Bueno M J ^a   Lahuerta Palacios, J J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Erythropoietin; Hepatitis; Iron toxicity; Phlebotomy

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIANEMIC AGENT; FERRITIN; RECOMBINANT ERYTHROPOIETIN;

ACUTE LEUKEMIA; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; FEMALE; FERRITIN BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HUMAN; IRON OVERLOAD; LIVER DISEASE; LIVER TOXICITY; PHLEBOTOMY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032969647     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701534     Document Type: Article

References (18)

1. Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996; 17: 75-80.
2. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
3. Locasciulli A, Alberti A, de Bock R et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group, Infectious Diseases Working Party. Bone Marrow Transplant 1994; 14: 833-837.
4. Brugnara C, Chambers LA, Malynn E et al. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993; 81: 956-964.
5. Bilgrami S, Bartolomeo A, Synnott V et al. Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy. Acta Haematol 1993; 89: 141-143.
6. Singhal S, Powles R, Treleaven J et al. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant 1996; 18: 1049-1055.
7. Frickhofen N, Wiesneth M, Jainta C et al. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 1994; 83: 1998-2004.
8. Locasciulli A, Bacigalupo A, VanLint MT et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407-411.
9. Rodriguez-Iñigo E, Tomas JF, Gomez-Garcia de Soria V et al. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study. Blood 1997; 90: 1326-1331.
10. Fargion S, Fracanzani AL, Sampietro M et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 1997; 9: 497-503.
11. Ljungman P, Johansson N, Aschan J et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995; 86: 1614-1618.
12. McKay PJ, Murphy JA, Cameron S et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 63-66.
13. Muretto P, Del Fiasco S, Angelucci E et al. Bone marrow transplantation in thalassemia: modifications of hepatic iron overload and associated lesions after long-term engrafting. Liver 1994; 14: 14-24.
14. Angelucci E, Muretto P, Lucarelli G et al. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 1997; 90: 994-998.
15. Carmine TC, Evans P, Bruchelt G et al. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Lett 1995; 94: 219-226.
16. Azar N, Valla D, Abdel-Samad I et al. Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 1996; 62: 56-61.
17. Harrison P, Neilson JR, Marwah SS et al. Role of non-transferrin bound iron in iron overload and liver dysfunction in long-term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol 1996; 49: 853-856.
18. Durken M, Agbenu J, Finckh B et al. A deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant 1995; 15: 757-762.